This information sheet discusses tuberculosis (TB) and the difference between the two TB-related conditions: latent TB infection (LTBI) and TB disease. It explains what is meant by LTBI, and, that although persons with LTBI cannot spread the disease, if left untreated, they can develop active TB in the future. The information sheet also describes active TB disease, its symptoms, and the need for treatment.
This 60-minute webinar reviews best practices for TB diagnosis and management for ICE detainees, the role of public health and community partners, and how care is coordinated for patients who are released.
This pamphlet is the introduction to a series of TB-specific cultural competency guides for the birth countries most commonly reported by foreign-born persons being treated for TB in the United States.
This monograph provides information for use by tribal, state, and local public health practitioners and their legal counsel to help improve their understanding and use of relevant laws to respond to challenges concerning TB control. Part I of the monograph contains an introduction and table listing resources on communicable disease and TB control methods in selected US jurisdictions. Part II presents a brief overview of some of the essential components of TB control, including a discussion of the international and national threats of the disease and modern public health interventions.
This report describes the investigation by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), which initially identified five confirmed cases of multidrug-resistant tuberculosis (MDR TB) in two distinct clusters, characterized by two distinct geographic locations, genotypes, and drug-susceptibility patterns in the Federated States of Micronesia. Extensive transmission had occurred among household contacts; 16 (8%) of the 205 contacts identified had confirmed or suspected MDR TB disease, and 124 (60%) had latent TB infection.
This report describes the investigation of a genotype cluster of eight tuberculosis cases in US born patients in the Detroit metropolitan area. The investigation was done by the Detroit Department of Health and Wellness Promotion, the Michigan Department of Community Health, and the Centers for Disease Control and Prevention. The first case was reported in a patient with drug-susceptible TB, who subsequently developed multidrug-resistant TB (MDR TB). Seven additional cases were reported in patients with TB genotypes matching that of the index patient.
